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Abstract
Obesity rates are rapidly increasing in Mississippi and the entire United States. It
is estimated that 34.9% o f Mississippi residents and 75 million Americans over the age of
20 are considered obese. Numerous studies have shown the high risk of developing co
morbidities once a person develops obesity. The number o f adult Americans living with
obesity and its associated co-morbidities is alarming. The purpose o f this study was to
determine which co-morbidities are most prevalent among obese residents o f rural
Mississippi and whether they can be reduced or reversed with significant weight
reduction. Nola Pender’s Health Promotion Model was utilized to guide the methods o f
this study. This study posed two separate questions. What percent o f obese adult patients
of rural health clinics in Mississippi have a co-morbidity associated with their obesity?
What are the most common co-morbidities associated with obesity among patients of
rural health clinics in Mississippi? This study examined the medical charts o f non
pregnant, adult patients o f three rural Mississippi health clinics who are 20 years o f age
or older, of any race, ethnicity, or gender, with a BMI >30. The data was gathered from
300 charts of patients who met the inclusion criteria and statistically analyzed to
determine which obesity-associated co-morbidities are most prevalent among this
population.
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Chapter I
Background Information and Statement of the Problem
The number of adult Americans living with obesity and its associated co
morbidities is alarming. Numerous studies have shown the high risk o f developing co
morbidities once a person develops obesity. The American Heart Association’s
Overweight and Obesity-2012 Statistical Fact Sheet states that 75 million Americans over
the age o f 20 are considered obese. The latest CDC findings on adult obesity reveal that
34.9% o f adult Mississippi residents are obese. A study performed by Guh et al in 2009
revealed a direct association between obesity and an increased incidence o f numerous
medical conditions including: type II diabetes mellitus, all cancers except esophageal and
prostate cancer, all cardiovascular diseases, asthma, gallbladder disease, osteoarthritis
and chronic back pain.
Because o f the prevalence o f obesity and its association with numerous co
morbidities, bariatric surgery is now recognized as a viable treatment option for those
with morbid obesity. Substantial weight loss from bariatric surgical procedures is
associated with either reversal or significant improvement in several co-morbid
conditions (Burke & Wang, 2011). Morbidly obese patients who underwent bariatric
surgery and were followed post-surgically were found to have resolution or significant
improvements o f type II diabetes mellitus, hypertension, dyslipidemia, metabolic
syndrome, non-alcoholic fatty liver disease, chronic kidney disease, left ventricular
hypertrophy and obstructive sleep apnea (Athyros, Tziomalos, Karagiannis, &
Mikhailidis, 2011).
Purpose of the Research Project

The purpose of this study was to determine which co-morbidities are most
prevalent among obese residents o f rural Mississippi and how they can be reduced or
reversed through significant weight reduction such as that with bariatric surgery.
Additionally, the researchers attempted to illustrate the benefits o f weight loss and the
reduction or reversal o f the co-morbidities associated with obesity.
Significance of the Research Project
The findings o f this study are significant to all healthcare providers who care for
obese patients. Over 1 billion adults are obese worldwide and obesity results in over 2.8
million deaths each year ("10 facts on obesity," 2012). The CDC reports that as weight
increases, the risk for coronary heart disease, cancer, hypertension, dyslipidemia, stroke,
liver disease, gallbladder disease, sleep apnea, respiratory problems, osteoarthritis, and
gynecological problems increase. Another statement by the CDC reveals that about 147
billion dollars were spent treating obesity in the United States alone in 2008. Less than
50% o f adults in America get the recommended amount o f daily exercise ("Adult obesity
facts," 2011). Obesity has become a global epidemic and Mississippi is the most obese
state in the union. Steps must be taken by all people in the United States to reduce excess
body weight, improve levels o f physical fitness, and reduce co-morbidities associated
with obesity. Health care spending on obesity and obesity related co-morbidities cannot
continue at this rate. Healthcare providers must become more proactive in finding ways
to treat and counsel obese individuals. Treatment plans and counseling must be initiated
as soon as obesity is identified to prevent or reverse the onset o f countless co-morbidity.
This study serves as an informative reminder o f the high rates o f obesity and the
associated co-morbidities to healthcare providers.

Limitations of the Research Project
The research project was limited because data was only gathered from three rural
health clinics in Mississippi. According to 2011 census data, the population o f
Mississippi is comprised o f 60% Caucasians and 37.3% African Americans. Different
results may be present if clinical sites included areas with a broader range of ethnic
groups. This study utilized a retrospective chart review and only data that was
documented in the charts was used. Results may differ or other data may be apparent if
examinations or interviews with human participants were carried out. A total o f 300
charts were reviewed to determine which co-morbidities are most prevalent among adult
residents o f Mississippi who are obese. Findings may have been skewed due to the small
sample size utilized for this study.
Definition of Terms
Body Mass Index (BMI)
Conceptual’. “A tool used to screen for overweight and obesity. In adults, BMI is
defined as weight in kilograms divided by the square o f the height in meters. A BMI of
25-29.9 indicates overweight and a BMI o f 30 or greater indicates obesity.” (R. Porter &
J. Kaplan (Eds.), 2011, pg 58).
Operational: A tool used to screen for overweight and obesity. Only data from
patients with a BMI o f 30 or greater will be utilized in this study.
Obesity
Conceptual: “An unhealthy accumulation o f body fat. Obesity is defined as
having a body mass index o f 30kg/m squared or greater. Obesity is the most common
metabolic/nutritional disease in the U.S. Obesity is more common in women, minorities,

and the poor. Obesity is the end result of an imbalance between food eaten and energy
expended, but the underlying causes are more complex. Genetic, hormonal, and
neurological influences all contribute to weight gain and loss.” (D. Venes (Ed.), 2009, pg
1614)
Operational: Obesity will be defined as having a BMI of 30 or greater and
Morbid Obesity shall be defined as a BMI greater than 40.
Co-Morbidity
Conceptual: A concomitant but unrelated pathologic disease process, the
coexistence o f two or more disease processes. (Lexicomp, 2012)
Operational: Co-morbidities o f obesity include but are not limited to, type II
diabetes mellitus, all cancers except esophageal, pancreatic, and prostate cancer, all
cardiovascular diseases except CHF, gallbladder disease, osteoarthritis, chronic back
pain, dyslipidemia, liver disease, respiratory problems, and gynecological problems.
Research Questions
The following research questions were created to guide the focus o f this study:
1. What percent o f obese adult patients o f rural health clinics in Mississippi have
CO-

morbidity associated with their obesity?
2. What are the most common co-morbidities associated with obesity among

patients o f

rural health clinics in Mississippi?

Conceptual Framework
Nola Pender’s Health Promotional Model (HPM) describes the multi-dimensional
nature o f persons as they interact within their environment to pursue health. The model
focuses mainly on the three following areas: individual characteristics and experiences.

behavior specific cognitions and affect, and behavioral outcomes. Nola Pender’s HPM
was designed to complement models o f health protection and defines health as “a positive
dynamic state, not merely the absence o f disease” ("Nursing theories," 2012, pg. 1). The
HPM describes the nature o f people as they interact within the environment around them
to pursue health. The main goal o f Pender’s theory and our current study is to promote
healthy behaviors that improve health, enhance functional ability, and improve quality of
life in all stages.
Pender’s HPM theoretical framework establishes several points that solidify the
idea that decisions regarding living a lifestyle that promotes health are acquired from
lived experiences and decisions regarding lifestyle changes are made based on the
perception o f which ones produce a more desirable result. Perceived barriers can prevent
one from selecting resolutions that would be beneficial in the promotion o f a healthy
lifestyle. Individuals must be encouraged and educated on the proper decisions to make
regarding their lifestyle choices. Greater perceived self-efficacy tends to result in fewer
perceived barriers to a specific health behavior. When positive emotions are associated
with a certain behavior, individuals are more likely to make decisions that promote
health. We, as nurses and future nurse practitioners, constitute part o f the interpersonal
environment that exerts influence on persons throughout their lifespan.
We used Pender’s Health Promotional Model (HPM) in our study because it is an
empowering, holistic, competence based model that does not use fear or threat as
motivation. The HPM has demonstrated fruitfulness as it describes new phenomenon and
reveals relationships between existing phenomena that were previously unknown. We
used the model as a basis for our theoretical framework throughout our study. The model

provided guidance as we strived to show how obesity placed individuals at a higher
incidence of obtaining certain chronic diseases. It also provided direction as we disclosed
the idea that certain lifestyle changes or interventions, such as bariatric surgery, can have
a profound effect on removing those same chronic diseases. The variables mentioned in
the above paragraphs were indicative throughout the research as we uncovered the many
co-morbidities associated with obesity and how they can be reversed with loss of excess
body weight.
Assumptions
It is well known and documented that more than 1 billion people worldwide are
obese. It is also well documented that people with obesity are at an extremely high risk of
developing numerous co-morbidities. With this information, assumptions regarding the
proposed study were made. First, it was assumed that primary care providers had
documented heights and weights o f all patients who have been seen in their clinic.
Second, it was assumed that any co-morbidity associated with obesity was documented in
the charts. Finally, it was assumed that the documentation in the charts was complete and
accurate.
Summary
Obesity has become the most prevalent metabolic or nutritional disease in the
United States. With over two-thirds o f the population being obese, Mississippi has the
highest obesity rate in the United States. The development o f numerous co-morbidities
has been linked to obesity. This study reviewed charts of obese patients in three rural
Mississippi health clinics in order to determine the percentage o f obese patients with one
or more co-morbidities, and the most frequently occurring co-morbidities. This study also

utilized prior studies on the results o f bariatric surgery to illustrate how significant weight
loss can reduce or reverse the co-morbidities associated with obesity.

Chapter II
Literature Review
Introduction
The purpose of this study was to determine which co-morbidities were most
prevalent among obese residents o f rural Mississippi and how they can be reduced or
reversed through significant weight reduction such as that with bariatric surgery. The
treatment o f obesity in the primary care clinic should be addressed with the client to
properly deal with the many co-morbidities of the disease. Addressing obesity and
stressing weight reduction should be the primary goal o f all healthcare providers.
The objective of this chapter was to present literature reviews that demonstrated
the relationship between weight loss and the significant reduction in the co-morbidities
associated with obesity. This chapter illustrated that reduction in weight contributed to
the decreased incidence o f the co-morbidities o f obesity.
Conceptual Framework
Nola Pender’s Health Promotional Model (HPM) was chosen as a framework for
the current research. The review o f literature, along with Pender’s theory, provided a
background and framework for the importance o f this study. The literature review
provided the results o f other studies that strongly related to the current study including
theorist Nola Pender and nine literature reviews. Nola Pender’s HPM described the multi
dimensional nature o f persons as they interact within their environment to pursue health
("Nursing Theories," 2012). Several articles related to Nola Pender’s HPM were
reviewed to establish points that solidified the idea that decisions surrounding lifestyle

changes that promote health are acquired from lived experiences. This section of chapter
two describes how the authors utilized Pender’s HPM in their studies.
The research article “Girls on the move program to increase physical activity
participation” objective was to evaluate the effectiveness o f combining nurse counseling
with a program to increase physical activity participation on the reversal o f the sedentary
lifestyles o f adolescent girls (Smith, Gretebeck, Kazanis, & Pender, 2006). The study
took place over a 12-week period and utilized girls in sixth, seventh, or eighth grade from
two Midwestern junior high schools in a low socioeconomic area. The study included 45
girls in the intervention group and 32 girls in the control group. At baseline, each girl
answered a questionnaire regarding their current level o f physical activity, and had their
height, weight, and BMI recorded. The researchers provided age specific
recommendations on physical activity for each girl in both the control group and
intervention group. The girls in the control group were then asked to return at 12 weeks
to answer a follow up questionnaire regarding physical activity levels and to have height,
weight, and BMI measured again. The girls in the intervention group received tailored
feedback and counseling from a nurse with special training in the area of health
promotion at three distinct periods during the 12 week study.
At the conclusion o f the study, the researchers discovered that no differences in
self-reported physical activity between the intervention or control group existed. The
study also found that no change was noted from pre-intervention to post-intervention
BMI for either group. The authors recommended that because no significant difference
emerged between the groups despite nurse counseling and individually tailored physical
activity feedback, a more robust intervention has to be developed (Smith et al., 2006).
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Increasing youth physical activity is a promising approach to decreasing the escalating
national overweight and obesity epidemic. The ultimate goal was to develop an effective
patient counseling intervention for diverse groups of children and adolescents (Smith et
al., 2006). The authors utilized Pender’s HPM in the study by attempting to modify the
subjects perceived benefits o f action, perceived barriers to action, and varying levels of
self-efficacy through counseling and feedback from healthcare professionals. This
concept was useful in our research as we took into account that the aforementioned
perceived barriers, benefits, and varying levels o f self-efficacy, often stand between
obese patients and the attainment o f healthy diets and lifestyles.
A 2006 article by Padula and Sullivan utilized a correlational study to identify
determinants o f health promotion activities among older adults who were in long-term
marriages. Selection o f study variables was aided by Nola Pender’s Health Promotion
Model and a proposed re-conceptualization o f interpersonal influences. They examined
the association between relationship quality and the dependent variable o f health
promotion behaviors and the independent variables o f perceived barriers to health
promotion, perceived self-efficacy, and social support. The study sample was comprised
o f 80 individuals from suburban and rural communities who spoke English and were able
to complete the pencil-and-paper measures independent from each other. Their data was
collected over a 9-month period in the participants’ homes. The data showed that the
majority o f participants were over 70 years o f age, identified their health as very good,
ranked their marriages as very happy, stated that they had four or fewer individuals in
their overall support network, identified their spouse as the their primary network source,
and identified their spouse as being very helpful in health related support.
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The study findings suggested that assessment and planning interventions should
focus on older married adults as individuals as well as members o f a couple. The
relationship between older, married adults is a vital component o f the plan of care
(Padula & Sullivan, 2006). The findings o f this study speak to the concepts o f Pender’s
HPM that family is a primary source o f interpersonal influence and perceived selfefficacy influences perceived barriers to action. The authors’ use o f the HPM in this
study was beneficial to our study, as we understood that familial influences and low
levels o f self-efficacy could also pose as barriers to action in achieving weight loss
among obese patients.
Kelly, Sherrod, and Smyth also used Nola Pender’s revised Health Promotion
Model as a conceptual framework in a 2009 study. This study was conducted utilizing a
descriptive retrospective chart audit in a small rural family clinic in a southern state. The
purpose o f the study was to determine whether or not primary care providers (PCPs) were
conducting smoking cessation therapy, whether a physician or nurse practitioner
conducted the smoking cessation therapy, and at what time frame smoking cessation
therapy was initiated in relation to diagnosis o f CAD. The study sample consisted o f 150
patients who had a history o f smoking and CAD. Over two-thirds o f the sample charts
contained documented smoking cessation therapy from a PCP at this clinic. O f the 150
patient charts in the sample, 103 o f them had documented smoking cessation therapy
prior to, or within one year o f being diagnosed with CAD. The two full time physicians at
the clinic were responsible for initiating 50% o f the therapy and the part time nurse
practitioner initiated 18.7% of the smoking cessation therapy (Kelley, Sherrod & Smyth,
2009).
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The authors utilized a portion of Pender’s Health Promotion Model Construct,
interpersonal influences, as it was the most relevant to this study. The data revealed that
the PCPs at this clinic recognized the importance o f interpersonal influences on smoking
cessation as evidenced by the level of smoking cessation therapy that was initiated. This
speaks to the theory that healthcare providers are primary sources o f interpersonal
influence. This application o f Pender’s HPM was useful in our study as we took into
account that healthcare providers must realize the importance of their interpersonal
influence and act upon it to elicit positive change among obese patients.
Another study was conducted by Murphey and Rew (2009) to identify the scope
o f oral health problems and describe three models to guide pediatric nursing research and
interventions related to oral health in pregnant minority adolescents. One o f the models
utilized was Nola Pender’s Health Promotion Model. The study utilized a meta-analysis
format. The article focused on dental caries, periodontal disease, pregnancy outcomes,
and potential consequences o f oral disease to young mothers and their offspring. The
study used Pender’s theory as a model to direct methods o f assessing perceived selfefficacy, barriers, beliefs, interpersonal influences, and situational influences that could
be utilized by nurses when dealing with this population. The authors explain that
Pender’s model is useful for assessing other characteristics such as previous experiences
and behaviors, demographic characteristics, and perceived health status.
The study revealed that the Health Promotion Model could be used as a way to
construct nursing interventions that could change the client’s perceptions in some o f the
areas mentioned above. This influenced our study by helping to grasp the understanding
that perceived self-efficacy, barriers, beliefs, interpersonal influences, and situational
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influences could all play a role in a patient’s willingness and ability to participate in a
plan to achieve any goal. Our research has benefitted from the knowledge that these
factors should be assessed by healthcare providers and taken into consideration when
formulating a plan o f care for weight reduction.
Review of Related Research
Related research was reviewed to reveal a relationship between weight reduction
and the improvement o f the co-morbidities associated with obesity. Other studies pertain
were reviewed pertaining to the effects o f obesity on lifelong morbidity and mortality.
Several studies revealed an improvement or resolution of type II diabetes mellitus,
hypertension, dyslipidemia, metabolic syndrome, non-alcoholic fatty liver disease,
chronic kidney disease, left ventricular hypertrophy and obstructive sleep apnea after
weight reduction (Athyros, Tziomalos, Karagiannis, & Mikhailidis, 2011).
In 2009, a literature search was performed in pursuit o f the top 20 co-morbidities
associated with overweight and obesity. In an effort to help us better understand the
correlation between overweight/obese individuals and their increased probability o f
developing other co-morbid diseases, the authors in this particular study performed a
systematic review and meta-analysis o f 89 prospective cohort studies. Quantitative
information was collected and compiled into charts displaying the co-morbidities and
their associated relative risks and incidence rate ratios. Medline, Embase, ISI Web of
Science, and Google Scholar databases were explored and preliminary data dating up to
January 2007 was extracted according to the inclusion criteria. Previous articles obtained
the following inclusion criteria: prospective cohort study o f the general population o f a
Western country, relevant outcomes, a sample size o f at least 200 subjects, and a risk
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estimate based on the incidence o f disease instead o f the mortality rate o f the disease.
Studies that were lacking in sufficient data to provide an unadjusted relative risks with
95% confidence intervals for the overweight and obese groups compared to the normal
group were eliminated. The original literature review began with more than 29,000
articles prior to the purging o f irrelevant articles.
The primary objective o f this study was to provide a comprehensive review o f the
incidence o f co-morbidities related to obesity and overweight (Guh et al., 2009). After
data was collected, relative ratios were measured by incidence rate ratios and by the
ratios o f proportion. Study specific unadjusted relative ratios on the log scale comparing
overweight with normal and obese with normal were weighted by the inverse o f their
corresponding variances to obtain a pooled relative ratio with a 95% confidence interval
(Guh et al., 2009). The random effects model was used to estimate the pooled RR using
the maximum likelihood estimation model.
The results o f the study varied depending on whether waist circumference (WC)
or BMI was used to determine obesity. The meta-analysis determined statistically
significant associations for overweight with incidence o f type II diabetes, all cancers
except esophageal (female), pancreatic and prostate cancer, all cardiovascular diseases
(except congestive heart failure), asthma, gallbladder disease osteoarthritis and chronic
back pain (Guh et al., 2009). Relative risks and incidence ratios were calculated and the
results confirmed that overweight and obesity carry a profound health burden and place
individual’s at a higher risk of developing one o f the listed 18 chronic health diseases.
WC was shown to be a superior predictor for type II diabetes, hypertension, coronary
artery disease, congestive heart failure, stroke, and gall bladder disease.

The
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researchers recommended a few variables that would have strengthened the study as a
whole. The exclusion o f the lack o f physical inactivity limited the study according to the
authors. Also, the lack o f studies linking waist circumference and certain co-morbidities
limited the ability to estimate the risk for certain co-morbidities. The literature research
was mainly performed through Medline and Embase, therefore bias may have occurred
secondary to the search strategy.
The study broadened our knowledge o f the profound effect that obesity has on
the body and its systems. An analysis was provided that showed the incidence o f
occurrence o f each o f the chronic co-morbidities. The article illustrated once again the
importance o f health promotion and dietary education. Maintenance o f a healthy weight
is imperative in the prevention o f an even larger disease burden in the future.
To help us better understand the correlation between obesity and the incidence of
hypertension, diabetes and certain metabolic syndromes, Drs. Hwang, Bai, Sun, and Chen
released the results o f their nation-wide population cohort study in 2011. Their analysis
o f both male and female participants gave a fairly broad spectrum view o f the general
population. The study employed data from the Taiwanese Survey on Prevalences of
Hypertension, Hyperglycemia, and Hyperlipidemia (TwSHHH). The original TwSHHH
was a nationwide epidemiological analysis o f 3,629 men and women ages 18-59. The
survey began in 2002 and follow-up examination and data collection was performed in
2007 (TwSHHH II). The mean length of follow-up was 5.4 years. Individuals were
excluded from this current study if they had hypertension. Type II diabetes mellitus,
history o f a stroke, or had any components of the metabolic syndrome. Inclusion criteria
narrowed the count to 1,547 subjects consisting of both men and women that were further
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subdivided into normal-weight, overweight, and obese BMI categories. The main goal of
the study was to describe the community incidences o f Type II diabetes mellitus,
hypertension and the metabolic syndrome and to investigate the impact o f obesity and
weight changes on these cardiometabolic diseases. (Hwang, Bai, Sun, & Chen, 2011, p.
228)
The data that was used in the study was collected by trained public health care
nurses via questionnaires during home visits. Baseline socio-demographic data was
collected at each visit such as: sex, age, exercise habit, alcohol drinking habit, smoking
habit, family history o f cardiovascular-related diseases and physician diagnosed diseases.
Blood pressure measurements were performed and most importantly BMI statistics were
gathered. The standard protocol for collection was performed identical at both collection
points. Written informed consents were obtained prior to initial data collection and before
follow-up data accumulation.
After the data was collected it was analyzed using SAS software. The
demographic characteristics o f subjects were compared between BMI categories via
ANCOVA test for continuous variables for age adjustment, and differences in proportion
data were assessed using the Cochrane-Amritage trend test (Hwang, Bai, Sun, & Chen,
2011, p. 228). Incidence rates of hypertension, DM Type II, and metabolic diseases were
calculated by dividing the new cases by the number o f years after follow-up. Hazard
ratios (HR) with 95% confidence intervals were derived by using the Cox’s proportional
hazards model to determine the 5.4 year risk of overweight and obesity for developing
hypertension. Type II DM, and the metabolic syndrome. The criteria for statistical
significance were p <0.05 and a 95% Cl o f HR.
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The results o f the study showed that obesity and weight gain are associated with
an increased risk for incidences o f hypertension, Type II DM, and metabolic disease. The
greatest significance was seen with increased incidences o f hypertension in those with
higher BMTs. The study showed that a normal body weight person had a 4.7 % increase
in hypertension over the 5.4 years while individuals with a BMI >27 had a dramatic
increase o f 20.9%. Metabolic syndrome also began to have significant increases in
incidences at BMI levels >23. The prevalence o f Type II DM also began to increase after
BMI levels reached 25. Each kg/ meter squared o f BMI gained was associated with an
18% increase in the risk o f developing hypertension and a 26% increase in the risk for
metabolic syndrome. The researchers brought to light the strong correlation between
overweight/obesity and the prevalence o f cardiometabolic diseases.
The researchers stated a few weaknesses and limitations o f the study mainly
regarding the classification o f a metabolically normal individual. During initial inclusion
participants were excluded if they had any components o f metabolic syndrome, however,
no data o f serum insulin or C-reactive protein were used for exclusion. Therefore, data
results could have been altered secondary to slightly limited exclusion/inclusion criteria.
The recommendations o f the researchers were mainly focused on the prevention
o f obesity and the implementation o f a weight management program in order to reduce
cardiometabolic diseases. This study was important to the current research project in that
it showed how imperative it is for individuals to maintain a healthy weight. The study
showed that incidences of developing hypertension, diabetes, and metabolic disease are
increased even more with continued weight gain. This study further broadened the
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knowledge regarding the profound correlation between overweight and obesity and the
prevalence o f certain cardiometabolic diseases.
In 2008, Burke and other researchers released the results o f their multi-ethnic
observational cohort study to demonstrate the impact o f obesity on cardiovascular disease
risk factors and subclinical valvular disease. Their analysis provided a superb opportunity
to evaluate the prevalence of cardiovascular disease risk factors in a large number of
overweight and obese individuals from different ethnic backgrounds. The study
employed data from the Multi-Ethnic Study o f Atherosclerosis (MESA). The MESA was
a nationwide diverse cohort study that gathered data from both and men women aging
from 45-84. The following ethnic groups were included in the analysis: Caucasian,
African American, Hispanic, and Chinese American. The survey began in July o f 2002
and ended in August o f 2004 with a total of 6,814 participants. The only inclusion
criterion was that the individual be free o f any clinically apparent cardiovascular disease
and not considered morbidly obese. Participants were thus excluded if they had a
previous diagnosis of CVD, any obvious signs o f the disease or BMI >40. The main goal
o f the study was to investigate the historical perspective that asserts that the association
between CVD and obesity is mediated virtually completed by traditional CVD risk
factors (Burke et al., 2008).
Participants were evaluated and information gathered at 6 field sites across the
United States. Baseline socio-demographic information was obtained through written
questionnaires. Also, participants were examined thoroughly for the existence of
cardiovascular disease risk factors by monitoring blood pressure, lipids, lipoproteins, and
diabetes. Subclinical vascular markers were also tested for including carotid artery
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intimai medial thickness, left ventricular mass, and coronary artery calcium score. Body
mass index (BMI) was determined and individuals were divided into three categories. All
blood samples were collected after a 12 hour fasting period. Computed tomography,
ultrasound, and magnetic imaging resonance were used to determine coronary calcium
assessment, carotid artery IMT, and left ventricular mass alike. Identical data collection
techniques, equipment, and imaging tools were used at each o f the clinical sites. Written
informed consents were obtained from each participant and the institutional review
boards from all participating centers approved the study prior to any data collection.
After the cross-sectional data was collected it was analyzed using SPSS and
Intercooled Stata software. In each sex and ethnic group, CVD risk factors were
compared across 3 level BMI groups. Linear regression models were used to tell the
differences in means. Relative risk (RR) regression models were used to compare
proportions for binary outcome variables. The RR coefficients were translated into
prevalence ratios. The RR regression models containing cardiovascular risk factors and
those containing subclinical markers were adjusted for age, sex, and race. Statistical
significance was defined as P <0.05. (Burke et al., 2008)
The results o f the study showed that hypertension, diabetes, and lower levels o f
HDL were more common in the obese populations despite a much higher usage of
hypertension and diabetic medications. Obesity was also associated with a higher risk of
increased coronary artery calcium (17%), common carotid IMT (45%), internal carotid
IMT (32%), and left ventricular mass (2.7 fold greater) compared to normal body mass
people. These correlations existed even after modifications were made for traditional
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CVD risk factors. The relationship o f CVD and obesity were common across all ethnic
backgrounds.
The study was informative and information rich. The fact that the study analyzed
both male and female subjects from multiple ethnicities provided a sample that was very
indicative o f today’s general population. However, the fact that morbidly obese
individuals were excluded from participation could have skewed the numbers to show a
somewhat lower risk group. This would have caused the results to be less indicative of
the actual general population. The fact that the data was also collected in a cross-sectional
manner could have altered the statistical analysis that was performed showing CVD risk
factors and its effects on actual atherosclerotic disease.

The authors recommended

that we begin to place even greater importance on the implantation o f a healthy lifestyle
and that we remove environmental barriers to maintaining a healthy weight for our
patients. The data gathered throughout the evaluation of this article further confirmed the
challenge we face as future practitioners to guide and direct our patients to a healthy
lifestyle. The epidemic of obesity clearly has a correlation to the many chronic diseases
people all over the world face today.
The authors’ study was helpful to the current research project in their
recommendation that increased weight has a large impact on the prevalence of obtaining
hypertension, diabetes, and decreased HDL levels. The study also indicated that obesity
amplifies the incidence o f individuals developing cardiovascular risks factors but that this
increased pattern is not seen in those that fall within a normal BMI range. Increased

.

weight has a direct impact on the development o f co-morbid conditions and the incidence
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o f increased mortality. The following review provides an alarming analysis linking
increased mortality to increased weight.
In 2011, Zimmermann and Sorensen conducted a quantitative study seeking to
discover the relationship between being obese in early adulthood and its impact on
lifelong, all-cause mortality. The authors understood that there was a strong link between
higher rates o f morbidity and mortality among obese men. This study’s aim was to
determine if entering young adulthood as an obese man increased the lifelong incidence
o f morbidity and mortality compared to non-obese men o f the same age group.
The list o f referenced articles dated back as far as 1977 but this study took place
over a 64-year period beginning in 1943. At least 10 of the articles used in the review
were less than five years old at the time this study was published. While there were some
outdated articles, most were current at the time o f this publication. No specific conceptual
or theoretical framework was listed for this study. This prospective cohort study included
all adult Danish men between the ages of 18 and 25 years who were required to be
examined by the Danish military draft board between 1943 and 1977. The men were
weighed and measured with bare feet, wearing nothing but underwear. Obesity was
defined as 35% overweight utilizing the Scandinavian standard that was in use at the time
o f this study. This number corresponds to a BMI of 31. The obese cohort had an average
BMI of 32.7, while the control cohort had an average BMI 21.4. All o f the participants
were then followed during the age span o f 18 to 80 years o f age, from the time o f the
draft board to the time o f their death, or October 31, 2007, whichever came first. The age
o f death among the obese sample was then compared with the age o f death among the
non-obese sample.
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The study did not mention exactly how the participant’s rights were protected.
However, no personally identifiable health information was found anywhere in the body
of this publication. The study was supported by grants from the Cluster for
Endocrinology and Metabolism, University o f Copenhagen, Denmark. Therefore, it
required approval from the IRB at the University o f Copenhagen, Denmark. The study
gathered data from a large sample studied over a 64-year period o f time. The population
was comprised o f 362,200 Danish men between the ages o f 18 and 25 years who were
required by law to be examined at the Danish military draft boards between the years of
1943 and 1977. This comprised approximately 93% o f the male population in Denmark
over the age o f 18 during this time period. Approximately 5% of the male Danish
population over the age o f 18 was excluded from the draft and this study due to severe
medical disabilities while another 2% were excluded due to having volunteered for
military duty prior to age 18. A randomized sample o f all Danish men who were required
to be examined by the draft board between the years o f 1943-1977 was included in the
sample selection. This randomized sample produced 1862 participants in the obese group,
and 3476 participants in the control group.
The study was to examine the relationship between the presence of obesity at the
time o f entering young adulthood and the influence it had on all cause morbidities and
mortality throughout the life span. The study utilized every single Danish man between
the ages of 18 and 25 years fi'om 1943 to 1977 who were eligible for draft board
examination. This included 97% o f the Danish men in this age group during that time
period. No other exclusion from the study was utilized. The data were analyzed using
Stata software version 9.2. The observation time for each participant was the period
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beginning on the date o f draft board examination until the date of death, age o f 80, loss to
follow up, or October 31, 2007, whichever came first. The only individuals who were
classified as lost to follow up were those who disappeared from the Civil Registration
Registry for unknown reasons. Cox proportional hazard regression was used to estimate
hazard ratios of mortality. Other methods such as stratified estimation, double NelsonAalen plot, and Kaplan-Meier method were used to offset putative confounding by the
draft board, differences in hazard o f mortality based on age group, allow baseline hazards
to differ by district, and to ensure that comparison o f men in the same age group
occurred. There was no stated level o f strength accepted.
The study discovered that 1191 o f the 5338 men died during follow up. The study
also identified that the men in the obese cohort had a lifelong doubling o f mortality when
compared with the control cohort. The authors also discovered that the men in the obese
cohort had a mean age o f death eight years earlier than the mean age o f death o f the
control group.
The authors recommended that further steps need to be taken to ensure that all
people know the chances of early death among men are doubled when entering early
adulthood with obesity. This article helps solidify the hypothesis that many co
morbidities are linked to obesity in adults. This study pointed out that men who enter
young adulthood with obesity are twice as likely to die early from all causes of mortality
than their non-obese peers.
Several articles were reviewed that further demonstrated that weight loss even
through bariatric surgery should be the primary focus o f treatment for obesity related co-

24

morbidities. These articles connected weight loss with the significant improvement
and/or the resolution o f the co-morbidities associated with obesity.
In 2008, Batsis et al conducted a quantitative study seeking to discover the
effects that bariatric surgery had on patients with metabolic syndrome and to examine the
predictors of metabolic syndrome resolution. The authors understood that substantial
evidence revealed insulin resistance as the main pathophysiological cause o f metabolic
syndrome. Research established that lifestyle modifications including increased physical
activity and a healthy diet are the best methods to reduce the incidence o f type II diabetes
and metabolic syndrome. Most dietary interventions alone produce no more than a 10%
reduction in body weight, which is often regained over time.
Bariatric surgery is an approved method o f achieving significant and longstanding
weight loss. With this knowledge in mind the authors hypothesized that bariatric surgery
would significantly increase weight loss, decrease insulin resistance, and ultimately,
decrease the prevalence o f metabolic syndrome. The majority o f the articles in their
review o f literature were current at the time of publication. The study was conducted
using a population-based, retrospective, cohort study. There were no specific details
listed concerning how the patient’s rights were protected. However, no personally
identifiable health information was identified anywhere in this article. The institutional
review boards o f the Mayo Clinic and the Olmstead Medical Center approved this study.
This population-based, retrospective, cohort study utilized all patients referred to
the Mayo Clinic’s site in Rochester, MN for bariatric surgery over a 14-year time period.
This time period was between January 1, 1990 and December 31, 2003. This yielded a
population o f 483 patients. After inclusion criteria were implemented, a sample selection
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o f 337 patients remained. Patients who met the Mayo Surgical Index, received Roux-enY gastric bypass surgery for weight reduction, had a BMI greater than 35, had complete
chart data, and had follow-up time o f three months or greater were included in the
surgical cohort. This yielded a surgical cohort o f 180 patients. The comparison cohort
was made up o f patients who were evaluated for bariatric surgery at the Mayo Clinic
Nutrition Center during the same time frame but did not undergo surgery. There were
several reasons these patients did not undergo the surgery including voluntarily declining,
denial by insurance, failure to maintain lifestyle interventions during their pre-surgical
evaluation period or psychiatric reasons. To be included in the comparison cohort, the
patients had to have a BMI greater than 35, have complete chart data, and follow up time
o f three months or greater. This resulted in a comparison cohort o f 157 patients. The
control cohort group underwent weight loss counseling, along with dietary and lifestyle
changes directed by the Mayo Clinic.
The data was collected utilizing retrospective chart reviews of the two cohort
groups at the Mayo Clinic in Rochester, MN. The two cohorts were then further broken
down into groups that had a diagnosis o f metabolic syndrome and groups that did not.
The patients had to have three o f the five components o f metabolic syndrome at the time
of surgery to be included in the group o f patients diagnosed as having metabolic
syndrome. The five components o f metabolic syndrome were increased serum TG levels,
low serum HDL-C levels, increased blood pressure, increased fasting plasma glucose,
and an increased waist circumference or BMI greater than 35. 156 patients, or 87%, of
the surgical cohort met the criteria for a diagnosis o f metabolic syndrome. 133 o f the
control cohort, or 85%, met the criteria for a diagnosis o f metabolic syndrome. The
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researchers avoided bias in sampling by using a population-based cohort. This included
all patients evaluated for bariatric surgery by the Mayo Clinic in Rochester, MN who met
the standardized inclusion criteria o f the study during this 14-year period. The statistical
methods utilized during the study included a 2-sided, paired t test, W ilcoxon signed rank
test, McNemar test, 2-sample t test o f unequal variances, W ilcoxon rank sum test, X 2
test, Fisher exact test, comparison o f 3-point scale distributions, Cochran-Armitage trend
test, logarithmic transformation, construction o f multiple logistic regression models, and
stratification o f quartiles according to follow up time. To analyze the sensitivity o f their
methods the authors used a carry-forward method o f imputation for patients lost to follow
up. The patients who were excluded from the analysis because o f missing data were
assumed to have metabolic syndrome at baseline and follow up. All statistical analyses
were performed using JMP for SAS, a program produced by the SAS institute in Cary,
NC. There was no stated level o f strength accepted.
The findings o f the study demonstrated that the surgical cohort had a much
greater decrease in excess body weight and decrease in the prevalence o f metabolic
syndrome than did the control cohort. However, overall prevalence o f metabolic
syndrome decreased significantly in both the surgical cohort and the control cohort. At
follow up, the surgical cohort had a 58% decrease in the overall prevalence o f metabolic
syndrome while the control cohort had a 10% decrease. At follow up, the control cohort
had a 99% obesity rate, while only 63% o f the surgical cohort remained obese. Multiple
logistical regressions of the entire cohort showed that the main predictor o f metabolic
syndrome resolution was the percentage o f excess weight loss. The percentage of excess
weight loss remained a highly significant predictor o f metabolic syndrome resolution
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after statistical adjustments were made for varying follow up times. Based on the findings
o f this study, the authors recommend that Roux-en-Y gastric bypass surgery be
considered as a treatment option for patients diagnosed with metabolic syndrome that
have not responded to more conservative weight reduction measures.
This article was useful to the study because it showed a direct relationship
between weight reduction and the reduction o f metabolic syndrome. Metabolic syndrome
is the name o f a diagnosis used when three o f five specific factors are present. This group
o f factors includes a large waistline, high triglycerides, low HDL cholesterol, high blood
pressure, and elevated fasting blood sugar. All five o f these factors are also considered
comorbidities o f obesity. This study solidifies the hypothesis that bariatric surgery can
have a profound impact on the reduction o f obesity and its associated comorbidities.
Sjostrom (2008) conducted a quantitative study based on the Swedish Obesity
Subjects (SOS) matching and intervention studies. The author was seeking to discover
the effects bariatric surgery had on morbidity and mortality at a 10-year post-operative
time compared to that o f the SOS study’s obese control group that did not undergo
surgery. He discussed the fact that many observational epidemiologic studies have shown
an increase in cardiovascular mortality after weight loss. He pointed out that the majority
o f these studies are limited in the fact that they cannot distinguish between intentional
and unintentional weight loss. He theorized that the observed weight loss in these studies
might not have been the cause o f increased mortality, but rather a side effect o f some
other condition that led to the increased mortality. The author hypothesized that
intentional weight loss, such as that with bariatric surgery, would lead to a reduction in
overall morbidity and mortality in obese patients.
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The SOS study methods included a 13.4-year recruitment campaign that resulted
in 11,453 subjects applying to take part in the study of which 6,905 completed a
matching examination. Inclusion criteria were implemented mandating that the subjects
had to be between the ages of 37 and 60, with a BMI of 34 or greater for men and 38 or
greater for women. These criteria reduced the population to a sample o f 4,047 subjects
who were chosen to take part in the SOS study. The subjects were allowed to choose
whether they desired bariatric surgery or to be in the control group. The final result was
2,010 subjects in the surgical group and 2,037 contemporaneously matched subjects in
the control group. The subjects in the surgical group underwent gastric banding, verticalbanded gastroplasty, or gastric bypass surgery. A matching program o f 18 matching
variables was implemented to match those o f the surgical group to those in the control
group. The follow up examinations and questionnaires for the surgically treated subjects
and their matched control cohorts were to be performed at six months and at 1, 2, 3, 4, 6,
8, 10, 15, and 20 years. The follow up times were calculated based on the date o f the
surgically treated subject’s operation. There was no specific mention o f how the
participants’ rights were protected but no personally identifiable health information was
found anywhere in this article. The institutional review board o f Sahlgrenska University
Hospital, Goteborg Sweden approved this study. The study design is an ongoing,
prospective, matched, surgical interventional trial. The study recruited participants and
performed the surgical procedures over a 13.4 year time period from September 1, 1987
through January 31, 2001.
The data was collected through follow-up examinations and questionnaires over a
20 year time period. The population was 11,453 Swedish subjects who initially applied
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for inclusion in the SOS study. The sample was 2,010 subjects in a surgical group and
2,037 subjects in a control group. The sample selection was based on completion o f a
matching profile by the applicants, males having a BMI o f 34 or greater, females having
a BMI o f 38 or greater, and being between the ages o f 37 and 60 at the time o f selection.
The data was collected at base line and postoperatively at six months and at 1, 2, 3, 4, 6,
8, 10, 15, and 20 years. The SOS study utilized physical examinations, lab work, and
questionnaires. The follow-ups for the surgically treated subjects and their matched
control cohorts were automatically scheduled by the SOS secretariat based on the date o f
surgically treated subject’s operation. The researchers avoided bias in sampling as all
applicants who filled out a matching profile, met the BMI criteria, and met the age
criteria were allowed to participate in the SOS study. The author o f this article. Dr. Lars
Sjostrom, is the chair o f the Swedish Obese Subjects study. He utilized the SOS study’s
statistical data that was previously recorded to complete this article. No further statistical
computation was needed to complete this article and no discussion about the SOS study’s
statistical methods is present in it. Dr. Sjostrom did use I-bar graphs, bar graphs, line
graphs and panels depicting odds ratios, percentages, and p values. The graphs and panels
were representations o f hypertriglyceridemia, low HDL, hypercholesterolemia, diabetes,
hypertension, hyperuricemia, weight changes, and mortality rates at different time
intervals. The graphs that were utilized in this article were directly from the SOS study
data and state a 95% confidence interval. There was no stated level o f strength accepted
in this article.
The article listed several significant study findings. The percentage o f body
weight lost by patients who underwent gastric bypass was 24-40% at 2 years, 14-36% at
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10 years, and 15-39% at 15 years. The percentage o f body weight lost by patients who
underwent vertical-banded gastroplasty was 14-34% at 2 years, 5-27% at 10 years, and 729% at 15 years. The percentage o f body weight lost by patients who underwent gastric
banding was 10-30% at 2 years, 0-28% at 10 years and between a 1% weight gain to 27%
loss at 15 years. The control group stayed within plus or minus 2% of their baseline
weight for the entire 15 years o f follow up for which data was available at the time o f this
publication. The 2 and 10 year recovery rates from diabetes, hypertriglyceridemia, low
levels o f high-density lipoprotein cholesterol, hypertension and hyperuricemia were much
better in the surgical group than in the control group. Over the follow-up period, the
surgical group experienced a less than 8% cumulative mortality rate while the control
group experienced a greater than 12% cumulative mortality rate.
The author recommends that bariatric surgery is a favorable option in the
treatment o f obesity. He based this recommendation on the fact that bariatric surgery is
the only obesity treatment that results in more than 15% weight loss over 10 years,
greatly effects established type II diabetes, helps prevent new cases o f type II diabetes,
and significantly reduces the mortality associated with obesity.
This article was useful to our study because it demonstrates a direct relationship
between bariatric surgery, weight loss, and the reduction o f obesity associated co
morbidities. It also illustrates a significantly lower risk o f mortality associated with
bariatric surgery when compared to the risk o f mortality associated with remaining obese.
Johnson and other researchers verified that the global obesity epidemic has been
well documented and is associated with multiple detrimental health outcomes. Bariatric
surgery has been noted to result in substantial and sustained weight loss in the majority of
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patients as well as successful resolution o f a number of comorbid conditions (Johnson et
al., 2012). Individuals with a history o f cardiovascular events are a population at high risk
o f premature mortality and although the safety o f bariatric surgery in patients with
established cardiovascular disease has been demonstrated, little is known about the midto long-term survival o f these patients after surgery (Johnson et al., 2012, p. 685).
Therefore, the purpose o f this study was to expound on the relationship o f bariatric
surgery with survival in a population o f morbidly obese patients with a history of
cardiovascular events (Johnson et al., 2012).
This quantitative research study obtained administrative inpatient hospitalization
data (i.e., UB92 Universal Billing Code o f 1992) from the South Carolina Office o f
Research and Statistics (SCORS) on all patients between 1996 and 2008 who met the
study inclusion criteria. The data had been collected from all South Carolina hospitals by
SCORS since 1995. Each patient was assigned a unique registiy identification that
allowed for linkage and tracking o f all reported patient records across multiple hospital
admissions and facilities. Death data were obtained from the South Carolina Department
o f Health and environmental Control Office o f Vital Statistics and linked to SCORS data
(Johnson et al., 2012). The study was approved by the Greenville Hospital System
University Medical Center Institutional Review Board and all patient linkages were
performed by SCORS personnel with all patient identifiers removed from the final linked
dataset before study analyses. Before querying the SCORS database for all inpatients
aged 40-79 years discharged between January 1, 1996 and December 31, 2008, with a
diagnosis o f morbid obesity (ICD-9-CM 278.01) and a primary surgical procedure of
interest, a review o f cases o f morbidly obese patients was done by our own institution.
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with Institutional Review Board approval as well (Johnson et al., 2012). During this
review, two groupings o f elective surgical procedures that were commonly performed in
morbidly obese patients were identified. Patients undergoing selected primary orthopedic
procedures (joint replacement/revision or spinal/vertebral/disc surgery) or gastrointestinal
procedures (cholecystectomy, hernia repair, or lysis of adhesions) were identified.
After a retrospective review o f medical records was conducted to verify the
demographic characteristics and co-morbidities o f the morbidly obese patients
undergoing these non-bariatric elective procedures were comparable with that of the
bariatric patients, these became our surgical control group (Johnson et al., 2012). O f these
morbidly obese patients that underwent bariatric surgery and were identified as having a
pre-surgical diagnoses of myocardial infarction/angina (ICD-9-CM diagnosis codes 410413) or stroke (ICD-9-CM diagnosis code 434) as considered for inclusion in the study.
The final dataset included all hospitalization and death data available on eligible patients
through December 31, 2008 (Johnson et al., 2012). All patients admitted non-emergently
and having an ICD-9-CM primary geriatric procedure code for gastric bypass (44.38,
44.39) or adjustable gastric banding (44.95) were identified as the bariatric cohort (BAR)
and any patient not having a bariatric procedure but having a primary orthopedic or
gastrointestinal procedure o f interest was then considered for inclusion in the surgical
control group. Patients having a primary outcome within 30 days o f the index procedure,
had missing or implausible data, or a history of non-primary bariatric surgery were
excluded (Johnson et al., 2012). Co-morbid conditions were evaluated for each
hospitalization and defined according to the corresponding ICD-9-CM diagnosis codes:
morbid obesity (278.01), hypertension (401), diabetes (250), dyslipidemia (272), sleep
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apnea (780.5), tobacco abuse (305.1), and history o f transient ischemic attack (435) and
were considered positive if occurring before or concurrent with the index surgical
procedure admission (Johnson et al., 2012). Primary outcome was death from any cause
as identified from hospital discharge records and South Carolina Department o f Health
and Environmental Control vital records. Patients not experiencing the outcome during
the study period were censored at the study end date of December 31, 2008 and
cardiovascular and non-cardiovascular mortality were evaluated as secondary outcomes
(Johnson et al., 2012).
Bivariate analyses were conducted using Fisher’s exact test for categorical data
and the Wilcoxson rank-sum test for continuous data (Johnson et al., 2012, p. 686).
Kaplan-Meier life table analysis was used to estimate survival, and the Log-rank test was
used to identify differences between groups (Johnson et al., 2012, p. 686). Cox
proportional hazards regression techniques were used to estimate hazard ratios (HR) and
95 per cent confidence intervals (Cl) using the PHREG procedure in SAS version 9.2
(Johnson et al., 2012, p. 686). Models were adjusted for all demographic characteristics,
co-morbid conditions, and cardiovascular event history, the proportional hazards
assumption as assessed by review o f log-log survival curves, and statistical significance
was assessed using an alpha = 0.05 (Johnson et al., 2012).
The results of the study were consistent with a 40 per cent relative risk reduction
in all-cause mortality associated with bariatric surgery in morbidly obese patients with a
history o f cardiovascular events (Johnson et al., 2012, p. 688). Younger and non-diabetic
patients having bariatric surgery demonstrated stronger estimated relative risk reduction
from deaths attributed to cardiovascular causes whereas older patients, as well as diabetic
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patients, experienced more marked reductions in deaths from non-cardiovascular causes
(Johnson et al., 2012). In addition to reporting results from this study, this article also
discussed results from the Swedish Obese Subjects Study (Johnson et ah, 2012), T. D.
Adams, et al (Johnson et al., 2012) and Flum and Dellinger (Johnson et al., 2012) studies.
The key strength o f this study was the inclusion o f a surgical control group (Johnson et
al., 2012). This should help eliminate the bias effect of including patients considered unfit
for elective surgery. Moreover, the choice o f procedures from which surgical controls
were selected was based on a review o f procedures commonly performed on morbidly
obese patients (Johnson et al., 2012).
This study demonstrated a significant survival advantage o f bariatric surgery for
the treatment o f obesity. This study further not only serves as strong evidence o f bariatric
surgery being associated with a significant decrease risk o f all-cause mortality due to
weight loss but with morbidly obese patients with a history o f major cardiovascular
events. These results also further demonstrate that bariatric surgery could be considered a
possible and sustainable treatment for the treatment o f morbid obesity, for weight loss,
especially with co-morbid conditions.
The article Bariatric Surgery fo r the treatment o f Obesity focused on bariatric
surgery as the standard of care for treatment of obesity (Eldar, Heneghan, Brethauer, &
Schauer, 2011). Because o f the rising prevalence of obesity and the high failure rates of
non-operative weight-reduction programs, bariatric surgery has become popular. Because
o f this popularity and an increased volume of bariatric cases, longer term follow-up is
now possible to formulate better outcomes o f bariatric surgery (Eldar et al., 2011). This
quantitative review summarized the published outcomes o f bariatric procedures including
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weight loss, perioperative morbidity and mortality, late complications as well as the
impact o f bariatric surgery on the co-morbidities o f obesity, cardiovascular risk and
mortality. The authors used data that was obtained from previous studies and ongoing
research to evaluate the current trends in bariatric procedures. They evaluated the
outcomes from the various procedures which enables informed decision making and
patient tailored procedure selection as well as helps the surgeon and the patient determine
realistic outcome expectations.
Data were collected from research obtained over the last decade on the different
types o f procedures and compared the effectiveness of each procedure leading to the
conclusions o f which procedures have become the most popular based on the number
performed worldwide (Eldar et al., 2011). The data collected also compared the
prevalence of procedures as used throughout the world especially in the United States and
Europe (Eldar et al., 2011). This article summarized data that was collected on the
perioperative morbidity and mortality rates. This data was obtained from other
researchers who conducted reviews and longitudinal assessments o f bariatric surgical
outcomes o f various procedures. The article also discussed the complications, morbidity
and mortality rates as reported by these studies. The study was conducted by compiling
the results obtained by collecting and compiling the results of various studies which
discussed the morbidity and mortality of different possible complications; events that
may occur early or late during the surgery or post-surgery. The most prevalent
complications associated with bariatric surgery were discussed as well as the incidence o f
potentially fatal complications. These complications included sepsis from an anastomotic
dehiscence, shock secondary to hemorrhage or cardiopulmonary events, thromboembolic
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events, gastrointestinal leaks and early bleeding episodes (Eldar et al., 2011). Long term
morbidity associated with the specific procedures were compared including narrowing of
the anastomosis resulting in strictures, car tissue formation, ulceration proximity o f the
gastrojejunal anastomosis, incisional and internal herniation as well as nutritional
deficiency o f the bariatric patient (Eldar et al., 2011).
The article went on to discuss the weight loss and the impact o f bariatric surgery
on the co-morbidities o f obesity including diabetes, hypertension and dyslipidemia. The
study reviewed the difference in degree o f improvement based on the specific procedures.
The resolution and/or improvement o f diabetes as well as the effects on hypertension and
dyslipidemia were found to be similar with long term follow-up (Eldar et al., 2011). The
impact o f weight loss from bariatric surgery on cardiovascular risk profile and overall
mortality was discussed as well. It was concluded that bariatric surgery significantly
reduces the risks for cardiovascular events, i.e. myocardial infarction, as well as cancer
and other cardiovascular diseases (Eldar et al., 2011). This article concluded that
bariatric surgery is a treatment for obesity which results in achieving substantial and
durable weight loss in addition to favorable metabolic effects far beyond those achieved
by lifestyle modifications and pharmacological treatments (Eldar et al., 2011). Given the
improvements and advances in laparoscopic surgery and improvements o f perioperative
morbidity and mortality rates, bariatric surgery has emerged as a safe and efficient
standard of care for the treatment o f severe obesity (Eldar et al., 2011). This article also
concluded statically that bariatric surgery is becoming an acceptable and viable option for
the treatment o f obesity and its co-morbidities (Eldar et al., 2011). This is significant for
the research of the group’s proposal o f providing evidence that bariatric surgery is a
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treatment option that should be considered an acceptable intervention along with other
non-surgical interventions for obesity (Eldar et al., 2011).
The strength o f this article is that these conclusions were obtained by more than
one source or study. This article used results collected from numerous studies which
obtained similar results. The weakness o f this study was that the authors, by using
previously conducted studies to obtain their data were not able to control any variables
that may have occurred either in conducting the research or collecting the data. This
article proved useful to support our project which showed that bariatric surgery could be
considered by the primary care provider and the patient as a primary treatment for obesity
and its co-morbidities through safe weight loss to significantly decrease the risks of
complications due to co-morbidities.
Athyros and others reported that morbid obesity represents a major healthcare
problem with increased incidence worldwide (Athyros, Tziomalos, Karagiannis, &
Mikhailidis, 2011). Obesity is associated with increased morbidity and is the leading
cause o f preventable deaths. The major co-morbidities associated with obesity include
type 2 diabetes mellitus, hypertension, dyslipidemia, metabolic syndrome, non-alcoholic
fatty liver disease, nephropathy, left ventricular hypertrophy and obstructive sleep apnea.
The authors o f this research were seeking to discover the benefits o f bariatric surgery for
weight loss in morbidly obese patients. They discovered that morbid obesity was largely
refractory to diet and drug therapy but generally responded well to bariatric surgery
(Athyros et al., 2011). The questions posed included: 1) what were the cardiovascular
effects o f bariatric surgeiy on the more common co-morbidities o f obesity; 2) was
bariatric surgery safe, and if so which o f the two more commonly performed procedures
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was more effective; and 3) the mechanisms underlying these effects o f the surgery
(Athyros et al., 2011). The authors were seeking to discover if weight loss by bariatric
surgery had any benefits o f resolution or decrease in the more common co-morbidities of
obesity (Athyros et al., 2011). These questions were based on the premise that weight
loss decreases the prevalence of the major co-morbidities o f obesity.
This retrospective quantitative study obtained data about patients who had
undergone bariatric surgery and were followed over a certain period. It looked at the data
collected regarding the resolution or the significant reduction o f the major co-morbidities,
comparing the data obtained with pre-surgery data (Athyros et al., 2011). The study also
compared the effectiveness o f the two more commonly performed bariatric procedures,
the laparoscopic adjustment gastric banding (LAGB) and laparoscopic Roux-en-Y gastric
bypass (LRYGB) and the overall safety and efficacy o f bariatric surgery (Athyros et al.,
2011). Data for this review was obtained from papers on MEDLINE, Current Content
and the Cochrane library published on bariatric surgery in English from January 1, 1990
to July 20, 2010 using certain keywords. Some data was also obtained from the
references o f retrieved articles for other pertinent materials (Athyros et al., 2011).
This article summarized the effects o f bariatric surgeiy on co-morbidities and
cardiovascular disease mortality as well as the mechanisms underlying those effects and
compared the safety and efficacy o f LAGB and LRYGB. The review article concluded
that bariatric surgery is considered an effective option for the management of morbid
obesity. It is both safe and beneficial to the patient and appears to reduce cardiovascular
mortality and the resolutions or reduction o f obesity related co-morbidities (Athyros et
al., 2011). Other findings o f the article were that significant decreases were observed
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when compared with the pre-surgery data for cardiovascular disease from 44% to 14%
and type 2 diabetes mellitus from 20% to 8% as well as significant decreases for other co
morbidities (Athyros et al., 2011). The study also showed a 99-100% prevention o f
progression to type 2 diabetes mellitus with patients who had impaired glucose
intolerance and a 64-93% resolution rate o f cases after surgery as well as a substantial
reduction in oral medication and/or insulin doses in patients whose diabetes was not
resolved (Athyros et al., 2011). There was also a significant decrease in systolic blood
pressure at 12 months after surgery with 46% o f the patients achieving complete
resolution of hypertension and another 19% showing significant improvement (Athyros et
al., 2011). The article also discovered significant decreases in dyslipidemia, metabolic
syndrome, nonalcoholic fatty liver disease, chronic kidney disease, left ventricular
hypertrophy as well as obstructive sleep apnea (Athyros et al., 20II).
These results are significant for our proposal Co-morbidities associated with adult
obesity in Mississippi in that they show that bariatric surgery is considered an effective
option for the management o f morbid obesity. Bariatric surgery is both safe and
beneficial in the treatment o f obesity appearing to reduce cardiovascular mortality and
resolution or significant reduction o f obesity related co-morbidities such as type 2
diabetes mellitus, hypertension, dyslipidemia and other major co-morbidities through
sustainable weight loss.
The major strength of this article was that the authors used several studies to
obtain data over a period o f time, which looked at long-term benefits and risks. The
studies used came to similar conclusions, giving certain strength to the article. This
however was a weakness o f the study as well. Because the authors relied on research of
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others they could not control the variables within the groups and therefore could not
account for any variables that may have affected the validity of the study.
This article was used in our topic to show that bariatric surgery, as a means o f
sustainable weight loss, is a viable, safe treatment option for the treatment o f obesity.
Bariatric surgery greatly reduces the co-morbidities associated with morbid obesity as
well as reducing the cardiovascular risk o f obese patients.
Conclusion
Obesity has become the most preventable nutritional disease in the United States
and Mississippi has the highest obesity rate in the United States. The development of
numerous co-morbidities has been linked to obesity. This review o f literature
demonstrated through research that sustainable weight loss significantly reduces or
resolves the co-morbidities associated with obesity. The literature review also
demonstrated that weight loss, obtained through bariatric surgery, greatly decreases the
risks of developing type II diabetes mellitus, all cancers except esophageal and prostate
cancer, all cardiovascular diseases, asthma, gallbladder disease, osteoarthritis and chronic
back pain.

Chapter III
Design and Methodology
This quantitative chart review was conducted to evaluate the most common comorbid conditions associated with obesity. Select literature reviews and data analysis
were also utilized to show how weight loss through bariatric surgical procedures
produced a decline in the number o f co-morbid conditions that were present prior to
weight loss. A quantitative, retrospective chart review was used to review 300 charts
from thee different clinical sites. This chapter defines the setting, sample, and the
implementation of the project.
Setting for the Research Project
The setting o f this research project was three rural health clinics. The three
clinics chosen were located in central Mississippi.
Population and Sample
The population for this research project was all patients receiving care at the
clinics mentioned above from January 2013 to March 2013. One hundred charts were
selected from each of the three clinics for a total of 300 charts using convenience
sampling. Charts were selected based on set criterion. Inclusion criteria consisted o f any
non-pregnant adults who were 20 years of age or older, of any race, ethnicity, or gender
that had a body mass index o f 30 or greater based on documented height and weight.
Implementation of the Project
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The researchers received Institutional Review Board approval from Mississippi
University for W omen (Appendix A). Written consent from each participating clinic was
obtained (Appendix B). The researchers involved in the study then evaluated 300 charts
that fit inclusion criteria and documented the presence or absence o f certain co-morbid
conditions. Data was collected at three clinics in the central Mississippi. This
retrospective chart review followed HIPPA guidelines and did not involve any human
participants. Confidentiality was maintained at all times to protect all information
obtained during the chart reviews. The chart reviews were placed on a data collection
worksheet approved by Mississippi University for Women (Appendix C). The data
collection sheet maintained confidentiality and refrained at all times from identifying
information. Numbers were used to avoid a break in confidentiality. The office managers
pulled the charts o f the aforementioned patients and placed them in a private room out o f
sight and secure from clinic traffic. Once the charts were in the private rooms, the
researchers examined them for the presence and frequency of recurring co-morbidities
based on the documentation in the charts. The data was recorded and saved on jum p
drives, the charts were immediately returned by the office manager, and the jum p drives
were kept secure to ensure patient confidentiality. The results o f this study might be
published; in which case neither the clinics’ nor the patients’ information will be
identifiable.
Data Analysis
Analysis was completed using specific statistical instruments that test each
question proposed by the researchers. Data was collected from the charts o f 300 patients
from rural health clinics in Mississippi. Subsequent analyses, such as descriptive statistics
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and chi square comparisons were performed using Minitab statistical software, version
16. An alpha value of 0.05 was used to determine significance. Graphical summaries
were produced using Minitab and Microsoft Excel, version 2010.

Chapter IV
Results
The obesity epidemic has become a severe public health crisis with more than 75
million Americans and approximately 1 billion people worldwide considered obese.
Mississippi is considered the most obese state in the United States with an alarming
34.9% o f adults considered obese. The results revealed that obese individuals are at an
increased risk o f acquiring certain co-morbid conditions. An alarming percent (93.3%) o f
the charts examined revealed the presence o f at least one o f the documented co-morbid
conditions. The purpose o f this study was to determine which co-morbidities are most
prevalent among obese residents of rural Mississippi and how they can be reduced or
reversed through significant weight reduction such as that with bariatric surgery.
Additionally, the researchers attempted to illustrate the benefits of weight loss and the
reduction or reversal of the co-morbidities associated with obesity. The following data
shows the percentage o f obese individuals with co-morbid conditions and the
corresponding most prevalent co-morbid conditions. This study also utilized prior studies
on the results of bariatric surgery to illustrate how significant weight loss can reduce or
reverse the co-morbidities associated with obesity.
Participant Characteristics
Data was collected from 300 medical charts of individuals o f different genders,
ages, and ethnicities o f whom were at least 20 years o f age, non-pregnant and possessed a
BMI o f 30 or greater. The medical charts were from three rural health clinics in central
Mississippi. A wide array o f demographic variances were noted which aided in better
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representing the general population. Table 1 will provide a summary o f the patient
demographics.

Count

Percentage
of Sample

Gender
Male

115

38.33%

Female

185

61.67%

1
20-30 years

34

11.33%

31-40 years

51

17.00%

41-64 years

147

49.00%

65 years and greater

68

22.67%

African-American

178

59.33%

Caucasian

115

38.33%

7

2.33%

30-34.9

112

37.33%

35-40

97

32.33%

40 or greater

91

30.33%

Age

Ethnicity

Other
BMI

Table 1. Summary o f patient demographics (n=300)
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Findings
1. What percent o f obese adult patients o f rural health clinics in Mississippi have a
co-morbidity associated with their obesity? The data collected revealed that
93.3% (n=280) o f the medical charts reviewed contained at least one co-morbid
condition. Only 6.7% o f the 300 obese patients did not have one o f the
documented co-morbid conditions.
35.0%

120. 0 %

29.7%
30.0%

100. 0 %

25.0%
80.0%
%

20.0%
60.0%

S

—

15.0%
40.0%

9.0%

10. 0%

E

3

6.7%

20. 0%

4.3%

5.0%

310%
1.3%

0.3%o.O%
0 . 0%

0 . 0%

N u m b er o f Co-IVIorbidities

Figure 1. Number o f total co-morbidities per patient (n=300)

2.

What are the most common co-morbidities associated with obesity among patients

o f rural health clinics in Mississippi? The incidence rate o f the ten co-morbidities
evaluated is shown in Figure 1. The sample had the highest incidences of
cardiovascular disease (66%), type II diabetes (43%), and dyslipidemia (40%). The
co-morbidities with the lowest incidence rates in the sample included gallbladder
disease (3%) and liver disease (6%).
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Figure 2. Incidence o f co-morbidity amongst the sample o f patient charts
(n=300)
Additional Findings:
The difference in BMI classification by various demographic factors is shown in
Table 2. Figure 3 displays the difference in BMI based on gender. The differences
between gender is statistically significant {^{2,N = 300)= \5A 10,p< 0.^0\). Females had
a significantly larger proportion o f patients with a BMI over 40. As shown in Figure 4,
the BMI o f the patients was also significantly different based on age classification
5.889,/>=0.014). The younger age groups had a significantly higher
percentage o f its patients with a BMI over 40. The differences in BMI across ethic
groups was also statistically significant (%^(4,A=300)=10.876, y?=0.028). African
American patients had a higher proportion o f its patients with a BMI over 40 (34.27%)
compared to the Caucasian ethnic group (25.22%).
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BMI
30-34.9

35-40

>40

Male

41.74%

40.87%

17.39%

Female

34.59%

27.03%

38.38%

20-30 years

20.59%

35.29%

44.12%

31-40 years

39.22%

19.61%

41.18%

41-64 years

36.73%

33.33%

29.93%

65 years and greater

45.59%

38.24%

16.18%

African-American

32.58%

33.15%

34.27%

Caucasian

41.74%

33.04%

25.22%

Other

85.71%

0.00%

14.29%

Gender

Age

Ethnicity

Table 2. BMI by gender, age, and ethnicity
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Summary
The researchers discovered that an overwhelming number o f obese individuals
possessed at least one co-morbid condition. O f the 300 medical charts reviewed, 93.3%
(n=280) of the charts contained one o f the co-morbid medical condition diagnoses. The
researchers were also able to isolate the most common co-morbid disorders associated
with obesity. Cardiovascular disease (66%), DM Type II (43%), and Dyslipidemia (40%)
were the most common conditions affecting the obese population.

Chapter V
Summary and Conclusions
Summary of the Investigation
The prevalence o f obesity in Mississippi is alarming as this state leads the nation
in the percentage rate o f obesity. Numerous studies have shown that the risk o f
developing co-morbidities increases once a person develops obesity. The purpose o f this
study was to determine which co-morbidities are most prevalent among obese residents
o f rural Mississippi and whether they can be reduced or reversed with significant weight
reduction. The study posed two questions; (1) What percent o f obese adult patients of
rural health clinics in Mississippi have a co-morbidity associated with their obesity, and
(2) What are the most common co-morbidities associated with obesity among the patients
o f rural health clinics in Mississippi. Nola Pender’s Health Promotion Model was used as
the framework for this study. After setting the framework, a tool was developed to assist
in data collection from randomized charts in three rural health clinics in Mississippi.
Once the data was collected, it was analyzed to answer the questions posed by this study.
This chapter covers the research findings, limitations, implications, recommendations,
and conclusion to this study.
Interpretations o f Findings and Conclusions
The first question posed by this study was what percentage o f obese adult patients
o f rural health clinics in Mississippi had a co-morbidity associated with obesity? In order
to get this percentage, one hundred randomly selected charts were reviewed in three rural
health care clinics for a total o f three hundred charts. The next question posed by this
study, what are the most common co-morbidities associated with obesity among the
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patients o f the rural health clinics in Mississippi, was answered by the data collected in
the rural health clinics. After data was collected, it was compiled in Microsoft Excel and
then analyzed using Mini Tab statistical software, version 16.
Outcomes Related to Research Questions
Research Question 1: What percentage of obese adult patients of rural health
clinics in Mississippi had a co-morbidity associated with obesity?
The researchers found that the vast majority, 250 patients or 93.3%, had at least
one co-morbidity associated with obesity. This means that only 6.7% o f obese patients
had no co-morbidities. The research also found that of these 93.3% who had co
morbidities, 66% had cardiovascular disease. These findings were supported by the
literature in that obesity and weight gain were associated with an increased risk of
developing certain co-morbidities (Hwang, Bai, Sun, & Chen, 2011).
Research Question 2: What are the most common co-morbidities associated with
obesity among the patients of the rural health clinics in Mississippi?
The researchers identified that the most common co-morbidities associated with
obese patients in rural health clinics in Mississippi were cardiovascular disease (66%),
type II diabetes (43%), and dyslipidemia (40%). These findings are consistent with the
literature in that studies determined statistically significant association for obesity and the
incidences o f type II diabetes, cardiovascular diseases including hypertension,
cardiovascular artery disease, and metabolic syndrome. (Hwang et al., 2011) and (Guh, et
al., 2009)
Literature Applications to the Outcomes
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The findings o f this study were in keeping with the results found in the review o f
literature. Studies conducted by Guh et al. (2009) and Hwang, Bai, Sun, & Chen (2011)
concluded that obesity significantly increases the incidence o f hypertension, type II
diabetes, metabolic diseases, cardiovascular diseases (except congestive heart failure),
asthma, gallbladder disease, osteoarthritis, and chronic back pain. The literature review
also established that weight reduction significantly reduces the risks for the co
morbidities associated with obesity. Several articles further demonstrated that weight
loss, even through bariatric surgeiy, should be the primary focus o f treatment for obesity
related co-morbidities. The research demonstrated in the articles established a connection
between weight loss and significant improvements and/or resolution o f the co-morbidities
associated with obesity (Batsis et al., 2008), (Johnson et al., 2012), and (Sjostrom 2008).
Other literature recommended that greater importance be placed on the implementation o f
a healthy lifestyle and the removal o f environmental barriers to maintaining a healthy
weight for our patients. (Burke et al., 2008).
Limitations
Limitations may exist in this research as the population, sample, and methods
were that o f convenience. The data may be skewed due to the small sample size utilized
for this study. A total o f 300 charts from 3 separate rural health clinics in Mississippi
were reviewed to determine which co-morbidities were most prevalent among adult
residents of Mississippi who are obese.
Limitations also existed due to data being collected only from three rural health
clinics in the state o f Mississippi. Different results may be present if clinical sites
included areas with a broader range o f ethnic groups as Mississippi 2011 census lists its
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populations as consisting of 60% Caucasians and 37.3% African Americans which is
different from results o f data from the rural health clinics. Our sample was comprised of
59.33% African Americans and 38.33% Caucasians. Also, this study utilized a
retrospective chart review and only data that was documented in the charts was used.
Implications and Recommendations
The implications o f the results o f this study for nursing practice are great. A clear
link is established between obesity and multiple co-morbidities through the research.
Nursing practice will benefit because the literature shows that prevalent co-morbidities
are not only treatable with medication regimens, but also by reduction o f weight in
patients who are obese. This provides the nurse practitioner a patient education platform
to teach each patient about medications, healthy lifestyles, exercise to reduce weight and
the complications o f obesity.
Nursing Theory
Nola Pender’s Health Promotion Model could be used as a way to construct
nursing interventions tailored to the patient’s perceptions and to address barriers to health
and wellness. Pender’s HPM can influence attitudes and beliefs. This, in turn, can
increase the patient’s willingness and ability to participate in a plan to achieve treatment
goals (Murphy and Rew, 2009). Achieving treatment goals would greatly improve or
resolve the incidence o f type II diabetes, hypertension, dyslipidemia and all o f the other
co-morbidities o f obesity.
Nursing Research
The impact of this study on nursing research is diverse. This study could be
expanded to identify the prevalence o f co-morbidities, not only in rural health clinics, but
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also the more densely populated urban areas in Mississippi. This study could also be
expanded to show the decrease in the prevalence o f co-morbidities o f patients who have
undergone bariatric procedures in Mississippi. Implications for research also include
recommendations for further research o f the incidence o f obesity in children and the
prevalence of co-morbidities focusing on prevention in order to benefit the future adult
population of Mississippi.
Advanced Nursing Practice
The implications o f this study on advanced nursing practice includes
recommendations to focus mainly on the prevention o f obesity and the implementation of
weight management programs in order to reduce the co-morbidities associated with
obesity. This study shows how imperative it is for patients to maintain a healthy weight,
especially when they are at high risk o f developing obesity related co-morbidities. The
researchers found through this study and the review o f literature that the chance o f
developing hypertension, type II diabetes, and hyperlipidemia is increased with weight
gain and obesity. The advanced practice nurse should develop patient education models
to reinforce weight management and medication regimens based on standards o f care for
the management o f the co-morbidities associated with obesity.
Nursing Practitioner Education
Nurse Practitioners face the challenge of guiding and directing our patients to a
healthy lifestyle. The epidemic o f obesity has a clear correlation to many chronic
diseases. This study exhibits the importance o f educating nurse practitioners regarding
weight management and the reduction o f obesity related co-morbidities among their
clients. It calls for the promotion of healthy behaviors, enhancement o f functional
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abilities, and the improvement in quality o f life among obese adults in rural Mississippi.
It also points to the need for treatment o f these chronic diseases associated with obesity
through medication regimens.
Summary
Obesity has become the most prevalent metabolic disease in the United States and
Mississippi has the highest obesity rates in the country. Obesity leads to the development
of multiple co-morbidities. Nurse Practitioners, especially in rural Mississippi, constitute
an integral part o f the interpersonal environment that exerts influence on patients
throughout their lifespan. Advanced practice nurses must focus on the prevention of
obesity and the implementation o f weight loss programs in order to reduce the incidence
o f the co-morbid diseases of obesity. Patients must be encouraged and educated on the
proper decisions to make regarding lifestyle changes to improve the management o f these
chronic diseases. Through a review o f literature for this project, it has been demonstrated
that sustainable weight loss significantly reduces or resolves the co-morbidities
associated with obesity. Nurse practitioners should incorporate these standards o f care
into their practice to provide the best care for all patients who entrust their lives to them.
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Appendix B
Letter o f Consent for Rural Health Clinic

Date
A rural health clinic in central Mississippi
SUBJECT: Permission to participate in a research project
Dear XXXX,
We are graduate students in the family nurse practitioner program at Mississippi
University for Women in Columbus, MS. As a program requirement, we are conducting a
research study to assess the most common co-morbid conditions associated with obesity.
Literature review and analysis will also be performed in order to show how weight loss,
particularly through bariatric surgery, can have a positive effect on decreasing these same
co-morbid conditions.
Your participation will involve granting us the privilege o f reviewing medical records o f
your clients who are over the age o f 20. As researchers, we understand that we must
maintain the confidentiality o f all information collected from the charts. This information
includes, but is not limited to, all identifying information and research data that we will
come into contact with while performing chart reviews. We agree to refrain from
discussing or disclosing any information regarding your clients. Each researcher will
receive HIPPA and Corporate Compliance training through the facility before beginning
the research. These chart reviews will be recorded on a Data Collection Tool. The
information will be entered into a computer data sheet. The data sheet will be saved to a
portable jum p drive which will be kept in a locked area. This area will only be accessible
by the researchers. After completion o f the project, all physical data will be destroyed.
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appropriately. The results o f this study may be published, but your name, the clinic, nor
any o f the patient’s information will be identifiable.
Your participation in this study is strictly voluntary. The possible benefit o f your
participation is that the research project will serve as a quality assurance measure for you.
The amount o f time required for us to review charts and collect data will be
approximately 1 day. After the research project is complete, we will provide you with the
results fi’om the study.
If you have any questions concerning this research study, please call Richmond
Lachney at (601) 416-9780, Daniel Walker at (601) 507-0392, Tonda Wells at (334) 8681692 or contact the chair o f our research committee, Dr. Patsy Smyth, at (662) 392-7321.
In addition, you may withdraw your consent and participation in this study at any time by
contacting me or the chair o f my research committee.

Sincerely,
Richmond Lachney, RN, BSN
Daniel Walker, RN, ESN
Tonda Wells, RN, BSN
^ ^ ^

^ 4* ^

^ ^ ^^ sjcsjcî|sî|cî^ î|ç!(cîjc

I have read this letter o f consent and have been given the opportunity to ask questions. I
give my consent to participate in the above study.

Clinic Manager

Signature

Date
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Appendix C
Data Collection Instrument (Proposed)

Chart#
1. Chart data complete (0) Yes (1) No
2. Age:_______ (0) 20-30 (1)31-40 (2)41-64 (3) >65
3. Gender: (0) Male (1) Female
4. Ethnicity: (0) African American (1) Caucasian (2) Other
5. Height:______
6. Weight:______
7. B M I:_______ (0) 30-34.9 (1) 35-40 (2) >40
8. Diabetes-Type II (0) Yes (1) No
9.

Cardiovascular Disease x CHF (0) Yes (1) No

10. Liver Disease (0) Yes (1) No
11. Dyslipidemia (0) Yes (1) No
12. Osteoarthritis (0) Yes (1) No
13. Respiratory Problems (0) Yes (1) No
14. Gynecological Problems (0) Yes (1) No
15. Gallbladder Disease (0) Yes (1) No
16. Chronic Back Pain (0) Yes (1) No
17. All cancers except esophageal, prostate, and pancreatic (0) Yes (1) No

